Integrity Buys Prenatal Vitamin Line from Wyeth-Ayerst

Privately held Integrity Pharmaceutical Corp. (Fishers, IN) has purchased the Stuartnatal line of prenatal vitamins from Wyeth-Ayerst Laboratories (Philadelphia) for an undisclosed amount. The purchase includes all U.S. rights to market and manufacture Stuartnatal Plus and Prenatal Plus, both prenatal vitamin supplements sold by prescription only, and Stuart Prenatal, a prenatal vitamin supplement available over the counter (OTC).

According to Keith Gates, CEO of Integrity, the Stuartnatal vitamin line will complement Integrity's strategy of providing quality pharmaceutical products to health care professionals in the obstetrics community. The combined market for all prenatal vitamins in 1999 was approximately $109 million.

Integrity will assume the distribution of the three products immediately.

Integrity Pharmaceutical Corp. is a privately owned, fully integrated pharmaceutical manufacturing company that focuses on providing the OB/GYN and urology specialties with quality pharmaceutical products.

Wyeth-Ayerst Laboratories, the pharmaceutical division of American Home Products Corp. (Madison, NJ), is a research-oriented pharmaceutical company with products in the areas of women's health care, cardiovascular therapies, central nervous system drugs, anti-inflammatory agents, infectious disease, hemophilia, oncology, vaccines, and generic pharmaceuticals.

For more information: Keith Gates, CEO, Integrity Pharmaceutical Corp., 9084 Technology Dr., Fishers, IN 46038. Tel: 800-823-6878. Fax: 317-558-2821. Email: kgates@integritypharma.com.

Edited by Jim Pomager